Patients experiencing early virologic failure on a protease inhibitor- or nonnucleoside reverse transcriptase inhibitor-based initial regimen containing a thymidine analogue and lamivudine can be successfully treated with a quadruple-nucleoside regimen [3]

Allan E Rodriguez, Christina Hill-Zabala, Louis Sloan, Thomas Jefferson, Linda Yau, Maria Watson, David Irlbeck, Mark Shaefer

Research output: Contribution to journalArticle

7 Scopus citations
Original languageEnglish
Pages (from-to)127-129
Number of pages3
JournalJournal of Acquired Immune Deficiency Syndromes
Issue number1
StatePublished - Jan 1 2006

ASJC Scopus subject areas

  • Virology
  • Immunology

Cite this